Provider of exosome-based liquid biopsy tests intended to provide accurate and painless early cancer detection. The company's bio-platform encapsulates ribonucleic acid and relates to physiological co...

Healthcare
Tokyo, Japan
Founded 2018
73 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$42.5M
Last Round
N/A

Get the full picture

Create a free account to unlock Craif's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required